[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100565179":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":10,"responsibleParty":22,"collaborators":10,"id":26,"slug":27,"hasResults":28,"nctId":29,"briefTitle":30,"officialTitle":30,"acronym":31,"eligibilityCriteria":32,"healthyVolunteers":28,"sex":33,"minAge":34,"maxAge":10,"enrollmentInfo":35,"targetDuration":38,"studyType":39,"phases":10,"briefSummary":40,"conditions":41,"keywords":47,"overallStatus":51,"whyStopped":10,"lastUpdateSubmitDate":52,"lastUpdatePostDateStruct":53,"startDateStruct":56,"completionDateStruct":58,"leadSponsor":60,"locationsCount":10},{"fullName":5,"class":6},"Treviso Regional Hospital","NETWORK",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Patients who will undergo surgery for hemorrhoidal disease after the diagnosis of IBD",null,"All patients with an established diagnosis of IBD who will undergo surgery for HD from January to December 2025 and followed-up for at least 1 year post-operatively will be prospectively included. Data on patient demographics and clinical characteristics, operative details and clinical outcomes will be collected.",[13,18],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Ugo Grossi, MD PhD","CONTACT","+39-3291649443","ugo.grossi@unipd.it",{"name":19,"role":15,"phone":20,"phoneExt":10,"email":21},"Chiara Carniel","+39-0422-322817","urc@aulss2.veneto.it",{"type":23,"investigatorFullName":24,"investigatorTitle":25,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Ugo Grossi","MD PhD, Assistant Professor of Surgery","100565179","hemorrhoidal-disease-in-inflammatory-bowel-disease-a-multicenter-prospective-cohort-study-100565179",false,"NCT06638814","HEmorrhoidAl Disease in Inflammatory Bowel Disease: a Multicenter Prospective Cohort Study","HEAD-IBD-II","Inclusion Criteria:\n\n* age of 18 years and above;\n* established diagnosis of Crohn's disease or ulcerative colitis at the time of surgery for hemorrhoidal disease;\n* planned surgery for hemorrhoidal disease during the study period, including hemorrhoidectomy (open, close or submucosal), transanal hemorrhoidal dearterialization, hemorrhoidal laser procedure, stapled hemorrhoidopexy).\n\nExclusion Criteria:\n\n* previous surgery for hemorrhoidal disease other than office-based treatments (e.g., sclerotherapy injection, rubber band ligation);\n* active perianal disease at the time of surgical intervention.","ALL","18 Years",{"count":36,"type":37},50,"ESTIMATED","12 Months","OBSERVATIONAL","Patients who will undergo surgery for HD after the diagnosis of IBD over a 12-month period will be enrolled across Europe.\n\nPrimary objective of this study is to determine the safety and effectiveness of surgical treatments for HD in a large multicenter cohort of IBD patients.\n\nSecondary aim is to identify factors that may affect clinical and surgical outcomes.",[42,43,44,45,46],"IBD (Inflammatory Bowel Disease)","Hemorrhoid","Safety","Sugery","Surgery Related Complications Rate",[31,48,49,50],"Hemorrhoidal disease","IBD","Surgery","NOT_YET_RECRUITING","2024-10-10",{"date":54,"type":55},"2024-10-15","ACTUAL",{"date":57,"type":37},"2025-01-01",{"date":59,"type":37},"2027-01-31",{"name":5,"class":6}]